194 related articles for article (PubMed ID: 15757388)
1. Recent developments in Neisseria meningitidis group A conjugate vaccines.
Frasch CE
Expert Opin Biol Ther; 2005 Feb; 5(2):273-80. PubMed ID: 15757388
[TBL] [Abstract][Full Text] [Related]
2. Meningococcal conjugate vaccines.
Zimmer SM; Stephens DS
Expert Opin Pharmacother; 2004 Apr; 5(4):855-63. PubMed ID: 15102568
[TBL] [Abstract][Full Text] [Related]
3. Technical Development of a New Meningococcal Conjugate Vaccine.
Frasch CE; Kapre SV; Lee CH; Préaud JM
Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S404-9. PubMed ID: 26553667
[TBL] [Abstract][Full Text] [Related]
4. Impact of serogroup A meningococcal conjugate vaccine for Africa.
Stuart JM
Hum Vaccin Immunother; 2018 May; 14(5):1116-1117. PubMed ID: 29194010
[TBL] [Abstract][Full Text] [Related]
5. Quadrivalent meningococcal conjugate vaccines.
Pace D; Pollard AJ; Messonier NE
Vaccine; 2009 Jun; 27 Suppl 2():B30-41. PubMed ID: 19477560
[TBL] [Abstract][Full Text] [Related]
6. Meningococcal vaccine evolution.
Bona G; Guidi C
J Prev Med Hyg; 2012 Sep; 53(3):131-5. PubMed ID: 23362617
[TBL] [Abstract][Full Text] [Related]
7. Serogroup B meningococcal vaccines.
Zimmer SM; Stephens DS
Curr Opin Investig Drugs; 2006 Aug; 7(8):733-9. PubMed ID: 16955685
[TBL] [Abstract][Full Text] [Related]
8. Polysaccharide vaccines for preventing serogroup A meningococcal meningitis.
Patel M; Lee CK
Cochrane Database Syst Rev; 2005 Jan; (1):CD001093. PubMed ID: 15674874
[TBL] [Abstract][Full Text] [Related]
9. Meningococcal quadrivalent (serogroups A, C, W135, and Y) conjugate vaccine (Menveo(®)): profile report.
Deeks ED
Paediatr Drugs; 2012 Feb; 14(1):63-5. PubMed ID: 22149552
[No Abstract] [Full Text] [Related]
10. Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps.
LaForce FM; Djingarey M; Viviani S; Preziosi MP
Hum Vaccin Immunother; 2018 May; 14(5):1098-1102. PubMed ID: 28968148
[TBL] [Abstract][Full Text] [Related]
11. Neisseria meningitidis serogroup A vaccines: an overview.
Vergnano S; Heath P
Expert Rev Vaccines; 2003 Aug; 2(4):571-82. PubMed ID: 14711341
[TBL] [Abstract][Full Text] [Related]
12. Towards an improved serogroup B Neisseria meningitidis vaccine.
Perrett KP; Pollard AJ
Expert Opin Biol Ther; 2005 Dec; 5(12):1611-25. PubMed ID: 16318425
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers.
McVernon J; Nolan T; Richmond P; Reynolds G; Nissen M; Lambert SB; Marshall H; Papa T; Rehm C
Pediatr Infect Dis J; 2012 Jan; 31(1):e15-23. PubMed ID: 22094636
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of serogroup A meningococcal vaccines in Africa: a demonstration project.
Soriano-Gabarró M; Rosenstein N; LaForce FM
J Health Popul Nutr; 2004 Sep; 22(3):275-85. PubMed ID: 15609780
[TBL] [Abstract][Full Text] [Related]
15. Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution.
Marc LaForce F; Ravenscroft N; Djingarey M; Viviani S
Vaccine; 2009 Jun; 27 Suppl 2():B13-9. PubMed ID: 19477559
[TBL] [Abstract][Full Text] [Related]
16. Meningococcal conjugate vaccines: efficacy and new combinations.
Sáfadi MA; Barros AP
J Pediatr (Rio J); 2006 Jul; 82(3 Suppl):S35-44. PubMed ID: 16826310
[TBL] [Abstract][Full Text] [Related]
17. Meningococcal glycoconjugate vaccines.
Gasparini R; Panatto D
Hum Vaccin; 2011 Feb; 7(2):170-82. PubMed ID: 21178398
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and safety of a meningococcal serogroup A, C, Y and W glycoconjugate vaccine, ACWY-TT.
Findlow H; Borrow R
Adv Ther; 2013 May; 30(5):431-58. PubMed ID: 23712402
[TBL] [Abstract][Full Text] [Related]
19. The epidemiology of meningococcal disease and the impact of vaccines.
Khatami A; Pollard AJ
Expert Rev Vaccines; 2010 Mar; 9(3):285-98. PubMed ID: 20218857
[TBL] [Abstract][Full Text] [Related]
20. Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa.
Okoko BJ; Idoko OT; Adegbola RA
Vaccine; 2009 Mar; 27(14):2023-9. PubMed ID: 19095025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
